Ganzhou Hemay Pharmaceutical Co., Ltd

This early-phase study tests a new drug called Hemay181 in 24 adults with advanced solid tumors that have stopped responding to standard treatments or have no standard therapy available. The main goal is to see if the drug can shrink tumors and to check for side effects. Particip…

This study looks at how the drug Hemay005 is processed in the body by people with mild or moderate liver problems compared to those with healthy livers. It involves 24 adults with psoriasis. The goal is to find safe and effective doses for patients with liver impairment.